OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Fenofibrate Use Is Associated With Lower Mortality and Fewer Cardiovascular Events in Patients With Diabetes: Results of 10,114 Patients From the Korean National Health Insurance Service Cohort
Sang‐Ho Jo, Hyewon Nam, Jeongwoo Lee, et al.
Diabetes Care (2021) Vol. 44, Iss. 8, pp. 1868-1876
Open Access | Times Cited: 17
Sang‐Ho Jo, Hyewon Nam, Jeongwoo Lee, et al.
Diabetes Care (2021) Vol. 44, Iss. 8, pp. 1868-1876
Open Access | Times Cited: 17
Showing 17 citing articles:
Aged bone marrow macrophages drive systemic aging and age-related dysfunction via extracellular vesicle-mediated induction of paracrine senescence
Jing Hou, Kaixuan Chen, Chen He, et al.
Nature Aging (2024) Vol. 4, Iss. 11, pp. 1562-1581
Open Access | Times Cited: 14
Jing Hou, Kaixuan Chen, Chen He, et al.
Nature Aging (2024) Vol. 4, Iss. 11, pp. 1562-1581
Open Access | Times Cited: 14
Role of Fenofibrate Use in Dyslipidemia and Related Comorbidities in the Asian Population: A Narrative Review
Chaicharn Deerochanawong, Sin Gon Kim, Yu-Cheng Chang
Diabetes & Metabolism Journal (2024) Vol. 48, Iss. 2, pp. 184-195
Open Access | Times Cited: 6
Chaicharn Deerochanawong, Sin Gon Kim, Yu-Cheng Chang
Diabetes & Metabolism Journal (2024) Vol. 48, Iss. 2, pp. 184-195
Open Access | Times Cited: 6
Fenofibrate and Heart Failure Outcomes in Patients With Type 2 Diabetes: Analysis From ACCORD
João Pedro Ferreira, Francisco Vasques‐Nóvoa, Diana Ferrão, et al.
Diabetes Care (2022) Vol. 45, Iss. 7, pp. 1584-1591
Open Access | Times Cited: 23
João Pedro Ferreira, Francisco Vasques‐Nóvoa, Diana Ferrão, et al.
Diabetes Care (2022) Vol. 45, Iss. 7, pp. 1584-1591
Open Access | Times Cited: 23
Benefits and drawbacks of statins and non-statin lipid lowering agents in carotid artery disease
Kosmas I. Paraskevas, Péter Gloviczki, Pier Luigi Antignani, et al.
Progress in Cardiovascular Diseases (2022) Vol. 73, pp. 41-47
Open Access | Times Cited: 23
Kosmas I. Paraskevas, Péter Gloviczki, Pier Luigi Antignani, et al.
Progress in Cardiovascular Diseases (2022) Vol. 73, pp. 41-47
Open Access | Times Cited: 23
Comparison of Operational Definition of Type 2 Diabetes Mellitus Based on Data from Korean National Health Insurance Service and Korea National Health and Nutrition Examination Survey
Jong Ha Baek, Yong‐Moon Park, Kyungdo Han, et al.
Diabetes & Metabolism Journal (2023) Vol. 47, Iss. 2, pp. 201-210
Open Access | Times Cited: 12
Jong Ha Baek, Yong‐Moon Park, Kyungdo Han, et al.
Diabetes & Metabolism Journal (2023) Vol. 47, Iss. 2, pp. 201-210
Open Access | Times Cited: 12
Fenofibrate add-on to statin treatment is associated with low all-cause death and cardiovascular disease in the general population with high triglyceride levels
Kyung‐Soo Kim, Sangmo Hong, Kyungdo Han, et al.
Metabolism (2022) Vol. 137, pp. 155327-155327
Closed Access | Times Cited: 14
Kyung‐Soo Kim, Sangmo Hong, Kyungdo Han, et al.
Metabolism (2022) Vol. 137, pp. 155327-155327
Closed Access | Times Cited: 14
Peroxisomal Fitness: A Potential Protective Mechanism of Fenofibrate against High Fat Diet-Induced Non-Alcoholic Fatty Liver Disease in Mice
Songling Jiang, Md Jamal Uddin, Xiaoying Yu, et al.
Diabetes & Metabolism Journal (2022) Vol. 46, Iss. 6, pp. 829-842
Open Access | Times Cited: 12
Songling Jiang, Md Jamal Uddin, Xiaoying Yu, et al.
Diabetes & Metabolism Journal (2022) Vol. 46, Iss. 6, pp. 829-842
Open Access | Times Cited: 12
Lower-limb peripheral arterial disease and amputations in people with diabetes: Risk factors, prognostic value and management
Ninon Foussard, Loubna Dari, Éric Ducasse, et al.
La Presse Médicale (2023) Vol. 52, Iss. 1, pp. 104164-104164
Open Access | Times Cited: 5
Ninon Foussard, Loubna Dari, Éric Ducasse, et al.
La Presse Médicale (2023) Vol. 52, Iss. 1, pp. 104164-104164
Open Access | Times Cited: 5
Associations of omega-3 fatty acids vs. fenofibrate with adverse cardiovascular outcomes in people with metabolic syndrome: propensity matched cohort study
Nam Hoon Kim, Ji Yoon Kim, Jimi Choi, et al.
European Heart Journal - Cardiovascular Pharmacotherapy (2023) Vol. 10, Iss. 2, pp. 118-127
Closed Access | Times Cited: 4
Nam Hoon Kim, Ji Yoon Kim, Jimi Choi, et al.
European Heart Journal - Cardiovascular Pharmacotherapy (2023) Vol. 10, Iss. 2, pp. 118-127
Closed Access | Times Cited: 4
Review and analysis of 2023 Clinical Guidelines for Lipid Metabolism Disorders
И. В. Сергиенко, М. В. Ежов
Russian Journal of Cardiology (2023) Vol. 28, Iss. 4S, pp. 5688-5688
Open Access | Times Cited: 4
И. В. Сергиенко, М. В. Ежов
Russian Journal of Cardiology (2023) Vol. 28, Iss. 4S, pp. 5688-5688
Open Access | Times Cited: 4
New data on NOVEL ORAL ANTICOAGULANT, SGLT2i, lipid treatment and genetics
Stefan Agewall
European Heart Journal - Cardiovascular Pharmacotherapy (2024) Vol. 10, Iss. 2, pp. 83-84
Open Access | Times Cited: 1
Stefan Agewall
European Heart Journal - Cardiovascular Pharmacotherapy (2024) Vol. 10, Iss. 2, pp. 83-84
Open Access | Times Cited: 1
Designing starch-based fenofibrate formulations using the melting method
Jeong Sun Sohn, Ye Eun Choi, Jin‐Seok Choi
International Journal of Biological Macromolecules (2024) Vol. 272, pp. 132903-132903
Closed Access | Times Cited: 1
Jeong Sun Sohn, Ye Eun Choi, Jin‐Seok Choi
International Journal of Biological Macromolecules (2024) Vol. 272, pp. 132903-132903
Closed Access | Times Cited: 1
Metabolic background as the basis for comorbidity in patients with type 2 diabetes mellitus
T. Yu. Demidova, Ф. О. Ушанова
Meditsinskiy sovet = Medical Council (2024), Iss. 6, pp. 45-52
Open Access
T. Yu. Demidova, Ф. О. Ушанова
Meditsinskiy sovet = Medical Council (2024), Iss. 6, pp. 45-52
Open Access
Согласованная позиция экспертов о роли гипертриглицеридемии в развитии осложнений сахарного диабета 2 типа
Г. П. Арутюнов, Г. Р Галстян, Ю. Демидова Т., et al.
Атеросклероз и дислипидемии (2024), Iss. 2(55), pp. 5-16
Open Access
Г. П. Арутюнов, Г. Р Галстян, Ю. Демидова Т., et al.
Атеросклероз и дислипидемии (2024), Iss. 2(55), pp. 5-16
Open Access
One in Five Atherosclerotic Cardiovascular Disease Events in Individuals With Diabetes Attributed to Elevated Remnant Cholesterol
Benjamin Nilsson Wadström, Kasper Mønsted Pedersen, Anders Berg Wulff, et al.
Diabetes/Metabolism Research and Reviews (2024) Vol. 40, Iss. 8
Closed Access
Benjamin Nilsson Wadström, Kasper Mønsted Pedersen, Anders Berg Wulff, et al.
Diabetes/Metabolism Research and Reviews (2024) Vol. 40, Iss. 8
Closed Access
Lipoproteins and Ischemic Stroke in Diabetes
Renato Quispe, Michael Goestch, Brigitte Kazzi, et al.
Contemporary diabetes (2023), pp. 503-522
Open Access
Renato Quispe, Michael Goestch, Brigitte Kazzi, et al.
Contemporary diabetes (2023), pp. 503-522
Open Access
Fenofibrat reduziert kardiovaskuläre Ereignisse
Susanne Krome
Diabetologie und Stoffwechsel (2021) Vol. 16, Iss. 06, pp. 430-430
Closed Access
Susanne Krome
Diabetologie und Stoffwechsel (2021) Vol. 16, Iss. 06, pp. 430-430
Closed Access
